C2I2.org
 Index to all volumes
  2008
  2007
  2006
  2005
  2004
  2003
 Useful web site addresses
 Contacting C2I2

Search for:
Type a word or a phrase. All forms of the word are searchable.

Click here to register to get free access to the newest editions on-line

Supported by


Rüdiger von Kummer MD is Professor of Diagnostic Radiology/ Neuroradiology and is Head of the Department of Neuroradiology at the University of Dresden, Germany. Prior to taking up these positions in 1996, Dr von Kummer worked at the University of Heidelberg School of Medicine for 25 years. For 13 of these years, he was Director of the Cerebral Vascular Research Laboratory and he also worked in the Departments of Neurology and Neuroradiology. Dr von Kummer’s research interests include the pathophysiology of cerebral circulation, together with MRI and CT in acute ischemia. He has published more than 170 original papers and has contributed to over 50 books.

Imanuel Dzialowski MD is a Stroke Fellow at the University of Calgary, Department of Neurosciences, Foothills Hospital. Before taking up this appointment, he participated in residencies in Neurology and Neuroradiology at the University of Dresden. The subject of his MD thesis was ‘CT monitoring of experimental ischaemic oedema during ischaemia and reperfusion’. He has published a number of papers with Dr von Kummer on imaging techniques in acute stroke.
Role of diagnostic radiology in the management of acute stroke

Imanuel Dzialowski1, Rüdiger von Kummer2
1 Department of Neurosciences, Stroke Program, University of Calgary, Alberta, Canada; 2 Department of Neuroradiology, University of Dresden, Germany

Address for correspondence:
Rüdiger von Kummer, MD
Professor of Neuroradiology
Head, Department of Neuroradiology
University Hospital, Fetscherstr. 74
D-01307 Dresden, Germany
Tel: +49-(351)-458-2660 Fax: +49-(351)-458-4370
Email: ruediger.vonkummer@uniklinikum-dresden.de

Abstract
This article discusses the clinical efficacy of diagnostic imaging in acute stroke. It compares computed tomography (CT) with magnetic resonance imaging (MRI) according to six different levels of clinical efficacy.

The feasibility of MRI is limited. Both CT and MRI have the technical capacity to exclude acute brain haemorrhage. CT detects irreversibly injured brain tissue with moderate reliability but high specificity. MRI displays ischaemic tissue highly conspicuously and with good sensitivity but cannot reliably distinguish between reversible and irreversible brain damage within the first hours following stroke onset. Both CT and MRI have great therapeutic impact by differentiating haemorrhagic from ischaemic stroke, thus allowing specific treatment to take place. CT has been shown to improve patients’ outcome within the first 6 hours following stroke onset and thereby reduce healthcare costs. The extent of early ischaemic oedema that is apparent on CT may identify patients who will not benefit from recanalisation therapy. MRI assessment of acute stroke patients may allow efficacious treatment beyond currently accepted time-windows by applying the perfusion-diffusion mismatch and assessment of arterial occlusion.

Full text >>